NCT03136146
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Acute Lymphoblastic Leukemia
Explore clinical trials studying Recurrent Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
22 public trials
7 recruiting studies
Recurrent Acute Lymphoblastic Leukemia trial results
NCT03128034
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +34 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03670966
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05418088
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +44 more
- Locations
-
- Nationwide Children's Hospital Columbus, Ohio, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03263572
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06777979
- Conditions
- Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, not recruiting
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia
NCT07166419
- Conditions
- Blast Crisis, Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Bone Marrow Diseases, +39 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
NCT05761171
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
Active, not recruiting
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
NCT03147612
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With BCR-ABL1, +27 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States